Ligand validation:4ZE1

X2N: POSACONAZOLE

X2N is a Ligand Of Interest in 4ZE1 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4ZE1_X2N_A_602	34%	69%	0.194	0.879	0.62	0.56	1	-	0	0	100%	1
6E8Q_X2N_A_602	44%	11%	0.19	0.916	1.81	2.4	7	20	0	0	100%	1
5TL8_X2N_A_502	77%	5%	0.102	0.94	2.11	3.21	12	21	0	0	100%	1
4J14_X2N_A_602	49%	16%	0.201	0.95	1.71	1.96	7	18	7	0	100%	1
2X2N_X2N_B_1479	48%	12%	0.155	0.899	1.88	2.13	9	16	0	0	100%	1
5FSA_X2N_A_590	46%	11%	0.203	0.939	1.91	2.22	8	19	4	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.